advertisement

World of Psychology


J&J Warned on Claims About Antipsychotic Drug

regulators have warned Johnson & Johnson unit Janssen Pharmaceutica that a letter sent to doctors about its Risperdal drug to treat schizophrenia and bipolar mania is misleading. In a warning disclosed on Tuesday, the Food and Drug Administration told Janssen that its November letter failed to disclose information added to Risperdal's labeling about excess blood sugar and diabetes and minimized the risk of serious events including coma and even death. The FDA also said the letter fails to recommend regular testing...

Prozac Affects Babies, Sexual Function, Report Says

One of the most popular antidepressants, best known by the brand name Prozac, can affect the development of babies when pregnant women take the drug, according to a government report released on Tuesday. Normal doses can cause babies to be born lighter and sleepier than normal, or make them jittery or cause respiratory problems, the panel appointed by the National Toxicology Program said. "These effects appear to result more readily from in utero exposure late in gestation," the report, issued for...

Sibling violence leads to battering in college dating

Brothers and sisters who fight while growing up lay the groundwork for battering their dates by the time they get to college, a new University of Florida study finds. In fact, the study found that sibling violence is a predictor of dating violence and is compounded by the experience of growing up in families where parent-to-child violence or parent-to-parent violence exists, said Virginia Noland, a UF professor of health science education.

"The findings suggest that sibling violence – the most common and least understood...

FDA Issues Approvable Letter for Expanded Labelling of Concerta (Methylphenidate) for Treatment of Attention Deficit Hyperactivity Disorder

McNeil Consumer & Specialty Pharmaceuticals has received an approvable letter from the Food and Drug Administration (FDA) for the use of Concerta® (methylphenidate HCl) CII Extended-release Tablets in adolescents with Attention Deficit Hyperactivity Disorder (ADHD), and to expand labeling to include a 72 mg dosing regimen. FDA approval is contingent upon agreement of final labeling and submission of additional analyses from existing...

We're heading down the road to Walden Pond this afternoon to celebrate the one-year anniversary of our engagement. (We're married now, but since I proposed to her at Walden Pond, it just seems like a beautiful spring-day chance to go revisit it...